MyAverix Finance
F · Healthcare
CSL LTD SPON.ADR 2 (CSJA)
Biotechnology
CSL LTD SPON.ADR 2 (CSJA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CSJA
CSL LTD SPON.ADR 2 (CSJA) — FAQ
What is CSJA's P/E ratio?
The price-to-earnings (P/E) ratio for CSL LTD SPON.ADR 2 (CSJA) is 25.00 (data as of 2026-05-23).
Does CSL LTD SPON.ADR 2 pay a dividend?
Dividend yield is not available in the current snapshot for CSL LTD SPON.ADR 2 (CSJA). Check the MyAverix Finance app for the latest dividend data.
What sector is CSL LTD SPON.ADR 2 in?
CSL LTD SPON.ADR 2 (CSJA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CSJA listed on?
CSJA is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.